Hongjun Li
Impact in
- Biomaterials top 0.2%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 0.5%
Papers in
-
- RNA Interference and Gene Delivery 14
- Oncology 36
- CAR-T cell therapy research 17
- Co-authors
- Jun Wang (18 shared papers)Zhen Gu (46 shared papers)Jin‐Zhi Du (11 shared papers)Xiao‐Jiao Du (10 shared papers)Xianzhu Yang (8 shared papers)Cong‐Fei Xu (5 shared papers)Song Shen (6 shared papers)Shuming Nie (2 shared papers)
- Journals
- Biomaterials (8 papers)ACS Nano (7 papers)Advanced Materials (6 papers)Nano Today (3 papers)Science Advances (3 papers)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Hongjun Li
146 papers receiving 6.8k citations
Hongjun Li's Hit Papers
Peers
Comparison fields: 5 of 148
- Biomaterials 2.1k
- Pharmaceutical Science 506
- Biomedical Engineering 3.2k
- Immunology 1.1k
- Molecular Biology 2.5k
Countries citing papers authored by Hongjun Li
This map shows the geographic impact of Hongjun Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongjun Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongjun Li more than expected).
Fields of papers citing papers by Hongjun Li
This network shows the impact of papers produced by Hongjun Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongjun Li. The network helps show where Hongjun Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Hongjun Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 153 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Stimuli-responsive clustered nanoparticles for improved tumor penetration and therapeutic efficacy Hit paper breakdown → | 2016 | 644 |
| 2 | Smart Superstructures with Ultrahigh pH-Sensitivity for Targeting Acidic Tumor Microenvironment: Instantaneous Size Switching and Improved Tumor Penetration Hit paper breakdown → | 2016 | 480 |
| 3 | 2015 | 309 | |
| 4 | Tailoring Materials for Modulation of Macrophage Fate Hit paper breakdown → | 2021 | 298 |
| 5 | Inhibition of post-surgery tumour recurrence via a hydrogel releasing CAR-T cells and anti-PDL1-conjugated platelets Hit paper breakdown → | 2021 | 292 |
| 6 | 2018 | 244 | |
| 7 | 2018 | 230 | |
| 8 | Bioorthogonal catalytic patch Hit paper breakdown → | 2021 | 212 |
| 9 | 2018 | 185 | |
| 10 | 2017 | 177 | |
| 11 | 2020 | 149 | |
| 12 | 2016 | 131 | |
| 13 | 2020 | 107 | |
| 14 | 2021 | 106 | |
| 15 | 2018 | 100 | |
| 16 | 2020 | 99 | |
| 17 | 2020 | 95 | |
| 18 | 2018 | 89 | |
| 19 | 2015 | 87 | |
| 20 | 2020 | 82 |
About Hongjun Li
Hongjun Li is a scholar working on Molecular Biology, Oncology, Immunology, Biomedical Engineering and Biomaterials, having authored 153 papers that have together received 6.8k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (20 papers), Nanoplatforms for cancer theranostics (20 papers), CAR-T cell therapy research (17 papers), Immunotherapy and Immune Responses (15 papers), RNA Interference and Gene Delivery (14 papers), Virus-based gene therapy research (11 papers), Immune cells in cancer (9 papers) and Cancer Research and Treatments (8 papers). The work is most often cited by research in Biomaterials (2.1k citations), Pharmaceutical Science (506 citations), Biomedical Engineering (3.2k citations), Immunology (1.1k citations) and Molecular Biology (2.5k citations). Hongjun Li has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Jun Wang, Zhen Gu, Jin‐Zhi Du, Xiao‐Jiao Du, Xianzhu Yang, Cong‐Fei Xu, Song Shen, Shuming Nie, Di Wen and Zejun Wang. Their work appears in journals such as Biomaterials, ACS Nano, Advanced Materials, Nano Today and Science Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.